Ceramide in Redox Signaling and Cardiovascular Diseases

被引:82
|
作者
Li, Xiang [1 ]
Becker, Katrin Anne [1 ]
Zhang, Yang [1 ]
机构
[1] Univ Duisburg Essen, Dept Mol Biol, D-45122 Essen, Germany
关键词
Acid sphingomyelinase; Ceramide; Reactive oxygen species; NADPH oxidases; NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; AORTIC SMOOTH-MUSCLE; ACID SPHINGOMYELINASE; NEUTRAL SPHINGOMYELINASE; CELL-DEATH; CORONARY-ARTERIES; ENDOTHELIAL-CELLS; NAD(P)H OXIDASE; DEPENDENT SPHINGOMYELINASE;
D O I
10.1159/000315104
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Lipid rafts are distinct cell membrane microdomains that consist of cholesterol, sphingolipids, and some associated proteins. Accumulating evidence suggests that activation of sphingomyelinase and generation of ceramide mediates clustering of lipid rafts to form large ceramide-enriched platforms, in which transmembrane signals are transmitted or amplified. Ceramide and reactive oxygen species (ROS) are involved in the modulation of the cell membrane and intracellular ion channels, cell proliferation and apoptotic cell death, neutrophil adhesion to the vessel wall, and vascular tone and in the development of cardiovascular diseases to name some important examples. Ceramide triggers the generation of ROS and increases oxidative stress in many mammalian cells and animal models. Moreover, inhibition of ROS generating enzymes or treatment of antioxidants impairs sphingomyelinase activation and ceramide production. Thus, a new concept has been proposed that ceramide-enriched raft platforms are important redox signaling platforms that amplify activation of ROS generating enzymes (e. g. NADPH oxidase family enzymes) and sphingomyelinases. The general function of ceramide to form redox signaling platforms amplifying oxdative stress might be critically involved in the dysfunction of vascular cells induced by death receptor ligands and stress stimuli contributing to the development of cardiovascular diseases. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:41 / 48
页数:8
相关论文
共 50 条
  • [1] Impact of exercise training on redox signaling in cardiovascular diseases
    Campos, Juliane C.
    Gomes, Katia M. S.
    Ferreira, Julio C. B.
    FOOD AND CHEMICAL TOXICOLOGY, 2013, 62 : 107 - 119
  • [2] The Interplay between Autophagy and Redox Signaling in Cardiovascular Diseases
    Botanska, Barbora
    Dovinova, Ima
    Barancik, Miroslav
    CELLS, 2022, 11 (07)
  • [3] Polyphenols in Regulation of Redox Signaling and Inflammation During Cardiovascular Diseases
    Niu, Ling
    He, Xiu-hua
    Wang, Qing-wen
    Fu, Ming-yu
    Xu, Feng
    Xue, Ying
    Wang, Zhen-zhou
    An, Xin-jiang
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 72 (02) : 485 - 494
  • [4] Polyphenols in Regulation of Redox Signaling and Inflammation During Cardiovascular Diseases
    Ling Niu
    Xiu-hua He
    Qing-wen Wang
    Ming-yu Fu
    Feng Xu
    Ying Xue
    Zhen-zhou Wang
    Xin-jiang An
    Cell Biochemistry and Biophysics, 2015, 72 : 485 - 494
  • [5] Emerging Roles of Ceramide in Cardiovascular Diseases
    Shu, Hongyang
    Peng, Yizhong
    Hang, Weijian
    Li, Na
    Zhou, Ning
    Wang, Dao Wen
    AGING AND DISEASE, 2022, 13 (01): : 232 - 245
  • [6] Redox regulation by thioredoxin in cardiovascular diseases
    Shioji, K
    Nakamura, H
    Masutani, H
    Yodoi, J
    ANTIOXIDANTS & REDOX SIGNALING, 2003, 5 (06) : 795 - 802
  • [7] Redox signaling in cardiovascular health and disease
    Madamanchi, Nageswara R.
    Runge, Marschall S.
    FREE RADICAL BIOLOGY AND MEDICINE, 2013, 61 : 473 - 501
  • [8] Redox signaling in inherited diseases of metabolism
    Jacobsen, Donald W.
    Hannibal, Luciana
    CURRENT OPINION IN PHYSIOLOGY, 2019, 9 : 48 - 55
  • [9] TGFβ Signaling and Cardiovascular Diseases
    Pardali, Evangelia
    ten Dijke, Peter
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2012, 8 (02): : 195 - 213
  • [10] Ceramide toxicity in cardiomyocytes: from Farber disease to cardiovascular diseases
    Fitzsimons, Lindsey A.
    Filippakis, Harilaos
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2025, 328 (02): : H323 - H326